柬埔寨北部恶性疟原虫PfCRT突变与哌喹耐药的分布及时间动态
该研究对2009至2017年柬埔寨北部收集的410株恶性疟原虫分离株进行pfcrt测序,并用定量PCR估算pfpm2与pfmdr1拷贝数。结果显示,2010年改用双氢青蒿素-哌喹后新出现的PfCRT突变流行率上升,至2017年超过98%的虫株携带这些突变;2014年后PfCRT F145I流行率下降,被耐药性较低但适应性更强的PfCRT等位基因竞争取代。改用青蒿琥酯-甲氟喹后,pfpm2扩增虫株流行率下降,近半数哌喹耐药的PfCRT突变株为pfpm2单拷贝。
要点
- 2010年改用双氢青蒿素-哌喹后新PfCRT突变流行率上升,2017年逾98%虫株携带。
- 2014年后F145I下降,被耐药性较低但适应性更强的PfCRT等位基因取代。
- 近半数哌喹耐药PfCRT突变株无pfpm2扩增,监测须纳入PfCRT突变。
核心结论
- 柬埔寨北部新出现的PfCRT突变在2010年改用双氢青蒿素-哌喹后流行率上升,至2017年超过98%的虫株携带这些突变。
- 大量缺乏pfpm2扩增的PfCRT突变株提示应将PfCRT突变纳入该地区哌喹耐药的分子监测。
- 需监测这些PfCRT突变株中的pfmdr1扩增,因甲氟喹压力增加可能导致对两药均耐药的突变株。
研究设计与样本
- 对2009至2017年柬埔寨北部收集的410株恶性疟原虫分离株,用PacBio扩增子测序或全基因组测序测定pfcrt序列。
- 用定量聚合酶链反应估算pfpm2与pfmdr1拷贝数。
主要发现
- 新出现的PfCRT突变流行率在2010年改用双氢青蒿素-哌喹后上升,至2017年超过98%的虫株携带这些突变。
- 2014年后PfCRT F145I流行率下降,被耐药性较低但适应性更强的PfCRT等位基因竞争取代。
- 改用青蒿琥酯-甲氟喹后,pfpm2扩增虫株流行率下降,近半数哌喹耐药的PfCRT突变株为pfpm2单拷贝。
临床怎么用
- 在柬埔寨北部等哌喹使用地区,分子监测哌喹耐药时应同时检测PfCRT突变与pfpm2拷贝数。
- 对携带PfCRT突变的虫株应监测pfmdr1扩增,以评估甲氟喹压力下双重耐药风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Newly emerged mutations within the Plasmodium falciparum chloroquine resistance transporter (PfCRT) can confer piperaquine resistance in the absence of amplified plasmepsin II (pfpm2). In this study, we estimated the prevalence of co-circulating piperaquine resistance mutations in P. falciparum isolates collected in northern Cambodia from 2009 to 2017. METHODS: The sequence of pfcrt was determined for 410 P. falciparum isolates using PacBio amplicon sequencing or whole genome sequencing. Quantitative polymerase chain reaction was used to estimate pfpm2 and pfmdr1 copy number. RESULTS: Newly emerged PfCRT mutations increased in prevalence after the change to dihydroartemisinin-piperaquine in 2010, with >98% of parasites harboring these mutations by 2017. After 2014, the prevalence of PfCRT F145I declined, being outcompeted by parasites with less resistant, but more fit PfCRT alleles. After the change to artesunate-mefloquine, the prevalence of parasites with amplified pfpm2 decreased, with nearly half of piperaquine-resistant PfCRT mutants having single-copy pfpm2. CONCLUSIONS: The large proportion of PfCRT mutants that lack pfpm2 amplification emphasizes the importance of including PfCRT mutations as part of molecular surveillance for piperaquine resistance in this region. Likewise, it is critical to monitor for amplified pfmdr1 in these PfCRT mutants, as increased mefloquine pressure could lead to mutants resistant to both drugs.
引用
- Shrestha B, Shah Z, Morgan AP, et al. Distribution and Temporal Dynamics of Plasmodium falciparum Chloroquine Resistance Transporter Mutations Associated With Piperaquine Resistance in Northern Cambodia. J Infect Dis. 2021. PMID: 33528566. doi:10.1093/infdis/jiab055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。